The Scientist

» European Commission and disease/medicine

Most Recent

image: Naturally Resistant HIV Foils Therapy

Naturally Resistant HIV Foils Therapy

By | June 8, 2012

New computational modeling suggests pre-existing HIV drug resistance mutations may contribute more to drug failure than previously thought.

0 Comments

image: Autistic Fish?

Autistic Fish?

By | June 7, 2012

Minnows living in water with psychoactive pharmaceuticals have autism-like gene expression profiles, pointing to an environmental trigger for the disorder.

2 Comments

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: $18M Grant to Be Re-reviewed

$18M Grant to Be Re-reviewed

By | June 1, 2012

A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.

5 Comments

image: Surgical Art

Surgical Art

By | June 1, 2012

InĀ 1929 and 1930, Johns Hopkins Medical School surgeon Warfield Firor carried out a series of experiments to determine how long blood could flow between animals with joined circulatory systems. Without using any anti-coagulants, Firor attempted to es

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Digging the Underground Life

Digging the Underground Life

By | June 1, 2012

A rare peek inside the subterranean home of the naked mole-rat

0 Comments

image: Messing with HIV

Messing with HIV

By | June 1, 2012

Sangamo Biosciences is putting a different spin on gene therapy. 

0 Comments

image: From Bones to Brains

From Bones to Brains

By | June 1, 2012

With the help of a mother, one researcher uncovered a common link between autism and a devastating bone disease.

2 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech